1 American Society of Hematology. Hemophilia: From Plasma to Recombinant Factors. Available at: http://www.hematology.org/About/History/50-Years/1524.aspx. Accessed on July 24, 2018.2 HEMLIBRA Product Monograph, August 2, 2018.3 Oldenburg J, et al. Emicizumab Prophylaxis in Hemophilia A with Inhibitors. The New England Journal of Medicine, July 13, 2017.4 HEMLIBRA Product Monograph, August 2, 2018.5 Canadian Hemophilia Society. All About Carriers – A Guide for Carriers of Hemophilia A and B. Available from: www.hemophilia.ca/wp-content/uploads/2018/04/AACFinal.pdf. Accessed on July 23, 2018.6 Canadian Hemophilia Society. All About Carriers – A Guide for Carriers of Hemophilia A and B. Available from: www.hemophilia.ca/wp-content/uploads/2018/04/AACFinal.pdf. Accessed on July 23, 2018.7 European Haemophilia Consortium. Bleeding Disorders – Inhibitors. Available from: https://www.ehc.eu/bleeding-disorders/inhibitors/. Accessed on July 23, 2018.8 HEMLIBRA Product Monograph, August 2, 2018.9 HEMLIBRA Product Monograph, August 2, 201810 HEMLIBRA Product Monograph, August 2, 2018.11 HEMLIBRA Product Monograph, August 2, 2018.12 HEMLIBRA Product Monograph, August 2, 2018.13 Canadian Hemophilia Society. All About Carriers – A Guide for Carriers of Hemophilia A and B. Available from: www.hemophilia.ca/wp-content/uploads/2018/04/AACFinal.pdf. Accessed on July 23, 2018.14 WFH. Guidelines for the management of haemophilia. 2012. Available from: http://www1.wfh.org/publications/files/pdf-1472.pdf. Accessed on July 23, 2018.15 Franchini M, Mannucci PM. Haemophilia A in the third millennium. Blood Rev 2013; 179-84.16 Franchini M, Mannucci PM. Haemophilia A in the third millennium. Blood Rev 2013; 179-84.17 Whelan SF, et al. Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of haemophilia A patients. Blood 2013; 121: 1039-48.18 HEMLIBRA Product Monograph, August 2, 2018.19 HEMLIBRA Product Monograph, August 2, 2018.20 HEMLIBRA Product Monograph, August 2, 2018. |